Archives
|
Entry
|
Blogger
|
Date
▴
|
Xconomist
|
Location
|
|
Biogen Idec, Elan Start First Cancer Trial With Tysabri
|
Luke Timmerman |
09/05/08 |
|
Boston
|
|
Pharmas Flock to Sermo, Biogen Idec Takes Another Tack with MS, $400M More for the Broad Institute, & More Life Sciences News
|
Rebecca Zacks |
09/04/08 |
|
Boston
|
|
ZymoGenetics Hands Over Atacicept Rights to Partner, Merck KGaA
|
Luke Timmerman |
09/03/08 |
|
Seattle
|
|
Corporate Life Sciences VCs on the Rise in New England—the List
|
Ryan McBride |
09/03/08 |
|
Boston
|
|
Proteostasis Therapeutics Procures $45M, Stealthy Startup Gets Serious About Shampoo, MA Life Sciences Center Chief Shares Her Plans, & More Life Sciences News
|
Rebecca Zacks |
08/27/08 |
|
Boston
|
|
Trubion Pushing Forward Arthritis Trials, Working to Re-Ignite the Spark for Investors
|
Luke Timmerman |
08/26/08 |
|
Seattle
|
|
Announcing Xconomy’s Next Forum: How to Build A Life Sciences Company
|
Robert Buderi |
08/25/08 |
|
Boston
|
|
Taligen CEO Aims to Develop Drugs For Inflammatory Diseases, Build Company in Cambridge
|
Luke Timmerman |
08/14/08 |
|
Boston
|
|
Follica’s Fortunes Growing, Icahn’s Biogen Holdings Mounting, Genzyme’s Mipomersen Work Progressing, & More Life Sciences News
|
Rebecca Zacks |
08/13/08 |
|
Boston
|
|
Stromedix Drug Gets Orphan Status
|
Rebecca Zacks |
08/12/08 |
|
Boston
|
|
Icahn Ups Biogen Idec Stake to 6 Percent—Bought Big on Tysabri Woes
|
Ryan McBride |
08/12/08 |
|
Boston
|
|
Vertex Cystic Fibrosis Program on the Rise, Biogen and Partner Fall on Tysabri News, Alnylam Stakes RNAa IP Claim, & More Life Sciences News
|
Rebecca Zacks |
08/06/08 |
|
Boston
|
|
Biogen Idec, Elan Shares Plummet on News of Two PML Cases With Tysabri
|
Luke Timmerman |
08/01/08 |
|
Boston
|
|
Biogen Idec, Elan Report Two New Cases of Rare Brain Infection in Tysabri Patients
|
Luke Timmerman |
07/31/08 |
|
Boston
|
|
Helicos Looking to Grow in Bay State, Thanks to Gov. Patrick’s Life Sciences Initiative
|
Luke Timmerman |
07/31/08 |
|
Boston
|
|
Icahn’s Nominee to Yahoo’s Board Winds up on Biogen Idec’s, Epix CEO Steps Down, Caliper Comes to Drugs’ Rescue, & More Life Sciences News
|
Rebecca Zacks |
07/30/08 |
|
Boston
|
|
Genzyme Pursues Multiple Sclerosis Market, Biogen Reports Progress in Same, BG Medicine Swallows $40 Million Cash Bolus, & More Life Sciences News
|
Rebecca Zacks |
07/23/08 |
|
Boston
|
|
Biogen Idec, Elan Say More Than 31,800 Patients Taking Tysabri For MS
|
Luke Timmerman |
07/22/08 |
|
Boston
|
|
Biogen Idec Isn’t Sweating Possible Sale of Genentech to Roche
|
Luke Timmerman |
07/22/08 |
|
Boston
|
|
Genzyme Reaching For a Slice From Biogen’s Breadbasket, Multiple Sclerosis Drugs
|
Luke Timmerman |
07/17/08 |
|
Boston
|
|
Health 2.0 Firms in the Spotlight, Biogen Board in the Clear, Alnylam in Asia, & More Life Sciences News
|
Rebecca Zacks |
06/25/08 |
|
Boston
|
|
Seeding Labs Kickstarts Science in Developing Countries
|
Erik Mellgren |
06/24/08 |
|
Boston
|
|
Icahn Nominee Concedes Defeat at Biogen Idec Annual Meeting
|
Robert Buderi |
06/19/08 |
|
Boston
|
|
Genzyme Seeks Dual Approval, Google Health Picks Another Massachusetts Partner, Biogen Shareholders To Provide Closure (Maybe), & More Life Science News
|
Rebecca Zacks |
06/19/08 |
|
Boston
|
|
Icahn Nominee to Biogen Idec Board Pledges to Work With Current Management to Restore Research Operations to Past Greatness
|
Robert Buderi |
06/18/08 |
|
Boston
|
|
Washington Biotechies Showing Off the Green (Trees) at BIO Conference
|
Luke Timmerman |
06/17/08 |
|
Seattle
|
|
Biogen Directors Win Backing From Third Advisory Firm, Icahn Could Be Heading For Defeat
|
Luke Timmerman |
06/12/08 |
|
Boston
|
|
Vertex Moves Hepatitis Drug Forward, Merrimack Rakes in $60M, Biogen and Icahn Trade Barbs, & More Life Sciences News
|
Rebecca Zacks |
06/12/08 |
|
Boston
|
|
Biogen Idec’s Nominees Win Support from Shareholder Advisory Firms
|
Luke Timmerman |
06/10/08 |
|
Boston
|
|
Icahn Jabs Biogen Idec, Says Its Board Had `Very Little’ Input in Sale Process
|
Luke Timmerman |
06/05/08 |
|
Boston
|
|
Page 1 of
3 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, and beyond.
© 2007-2008 Xconomy. All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
